Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment
Clinical trial NCT01564056 · COMPLETED
Trial details
- NCT number
- NCT01564056
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-12
- Primary completion
- 2022-04-11
- Enrollment
- 1989
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.